FrancophonIA/ELRC3.0 huggingface dataset:
English: p-value is from the pairwise comparison of methotrexate monotherapy and adalimumab/methotrexate combination therapy using the Mann-Whitney U test. p-value is from the pairwise comparison of adalimumab monotherapy and adalimumab/methotrexate combination therapy using the Mann-Whitney U test p-value is from the pairwise comparison of adalimumab monotherapy and methotrexate monotherapy
Danish: p-værdi a p-værdi b p-værdi p-værdien for den parvise sammenligning af methotrexat-monoterapi og adalimumab/methotrexatkombinationsbehandling ved anvendelse af Mann-Whitney U test. p-værdien for den parvise sammenligning af adalimumab-monoterapi og adalimumab/methotrexatkombinationsbehandling ved anvendelse af Mann-Whitney U test p-værdien for den parvise sammenligning af adalimumab-monoterapi og methotrexat-monoterapi ved anvendelse af
English: Very Common Uncommon
Danish: Ikke almindelig Nykturi
English: ***, **, * Statistically significant at p < 0.001, < 0.01, and < 0.05, respectively, for all comparisons between
Danish: ***, **, * Statistisk signifikant ved henholdvis p < 0,001, < 0,01 og < 0,05 for alle sammenligninger mellem adalimumab og
English: • lung diseases causing shortness of breath (including inflammation);
Danish: • lungesygdom som forårsager kortåndethed (inklusive inflammation/vævsirritation)
English: The mean (± SD) serum adalimumab trough concentrations achieved at week 4 were 15.7±6.6 μg/mL for patients ≥ 40 kg (160/80 mg) and 10.6 ± 6.1 μg/mL for patients
Danish: De gennemsnitlige dal-serumkoncentrationer (± SD) af adalimumab, som blev opnået ved uge 4, var 15,7 ± 6,6 µg/ml for patienter ≥ 40 kg (160/80 mg) og 10,6 ± 6,1 µg/ml for patienter < 40 kg (80/40 mg).
English: Adalimumab has not been studied in patients with hepatic or renal impairment
Danish: Adalimumab er ikke undersøgt hos patienter med nedsat lever- eller nyrefunktion.
English: Cyltezo is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are
Danish: Cyltezo er indiceret til behandling af moderat til svær kronisk plaque-psoriasis hos voksne patienter,
English: 2) Inspect pre-filled syringe
Danish: 2) Inspicer den fyldte injektionssprøjte
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SYRINGE LABEL
Danish: MINDSTEKRAV TIL MÆRKNING PÅ SMÅ INDRE EMBALLAGER INJEKTIONSSPRØJTEETIKET
English: Non-infectious uveitis in adults and children Non-infectious uveitis is an inflammatory disease affecting certain parts of the eye. Cyltezo works by
Danish: Ikke-infektiøs uveitis er en betændelseslignende (inflammatorisk) sygdom, som påvirker bestemte dele af øjet.
English: Among patients whose adalimumab treatment was withdrawn at week 12 in Studies HS-I and HS-II, the HiSCR rate 12 weeks after re-introduction of adalimumab 40 mg weekly returned to levels similar to that
Danish: Blandt patienter, som fik afbrudt behandlingen med adalimumab ved uge 12 i HS-studie I og II, var HiSCR-raten 12 uger efter genoptagelse af behandling med adalimumab 40 mg ugentlig tilbage på samme niveau, som før behandlingsafbrydelsen (56,0 %).
English: Cyltezo dose for patients with enthesitis-related arthritis
Danish: Cyltezo dosis til patienter med entesopati relateret artrit
English: In controlled Phase 3 trials of adalimumab in patients with Crohn's disease and ulcerative colitis with a control period ranging from 4 to 52 weeks, ALT elevations ≥ 3 x ULN occurred in 0.9 % of adalimumabtreated patients and 0.9 % of controlled-treated patients.
Danish: I kontrollerede fase 3-studier af adalimumab hos patienter med Crohns sygdom og colitis ulcerosa med en kontrolperiode på 4 til 52 uger forekom ALAT-stigninger ≥ 3 x ULN hos 0,9 % af de adalimumabbehandlede patienter og 0,9% af de kontrol-behandlede patienter.
English: Worsening or new onset of psoriasis (including palmoplantar pustular psoriasis) urticaria, bruising (including purpura), dermatitis (including eczema), onychoclasis, hyperhidrosis, alopecia pruritus
Danish: , urticaria, tendens til blå mærker (inklusive purpura), dermatitis (inklusive eksem), onychoclasis, hyperhidrose, , pruritus
English: Patients were randomised to receive either 24 mg/m² body surface area (BSA) of adalimumab up to a maximum of 40 mg, or placebo every other week for 12 weeks.
Danish: Patienterne blev randomiseret til at få enten adalimumab 24 mg/m2 legemsoverfladeareal (BSA) op til maksimalt 40 mg eller placebo hver anden uge i 12 uger.
English: The infections consisted primarily of nasopharyngitis, upper respiratory tract infection, and sinusitis.
Danish: Infektionerne var primært øvre luftvejsinfektioner, bronkitis og sinuitis.
English: Cyltezo 40 mg solution for injection in pre-filled syringe Cyltezo 40 mg solution for injection in single-use pre-filled syringe (type I glass) with a plunger stopper (butyl rubber) and a needle with a cap (outer part made of plastic material and inner part made of elastomer containing latex).
Danish: Cyltezo 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte Cyltezo 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte til engangsbrug (type 1-glas) med stempelprop (butylgummi) og kanyle med en beskyttelseshætte (ydre del fremstillet af plasticmateriale og indre del fremstillet af elastomer, der indeholder latex).
English: * p < 0.001 for adalimumab versus placebo pairwise comparisons of proportions ** p < 0.02 for adalimumab versus placebo pairwise comparisons of proportions
Danish: * p < 0,001 for adalimumab vs. placebo parvise sammenligninger af andelene ** p < 0,02 for adalimumab vs. placebo parvise sammenligninger af andelene
English: The recommended dose of adalimumab for patients with polyarticular juvenile idiopathic arthritis from 2 years of age is based on body weight (Table 1).
Danish: Den anbefalede adalimumab-dosis til patienter fra 2 år med polyartikulær juvenil idiopatisk artrit er baseret på legemsvægt (tabel 1).
English: The combination of Cyltezo and abatacept is not recommended (see section 4.4 “Concurrent administration of biologic DMARDS or TNF-antagonists”).
Danish: 4.4 “Samtidig administration af biologiske DMARDs eller TNF-antagonister”).
English: Patients subsequently underwent a mandatory taper schedule, with complete corticosteroid discontinuation by week 19.
Danish: Efterfølgende fulgte patienterne en obligatorisk nedtrapningsplan med komplet seponering af
English: Hepatosplenic T-cell lymphoma Merkel cell carcinoma (neuroendocrine carcinoma of the skin)
Danish: , Merkelcelle karcinom (neuroendokrint karcinom)
English: Should treatment be interrupted, Cyltezo 40 mg every week or 80 mg every other week may be re-introduced
Danish: Hvis det bliver nødvendigt at afbryde behandlingen, kan der startes op igen med Cyltezo 40 mg hver uge eller 80 mg hver anden uge (se pkt.
English: For patients who dose escalated from eow to weekly regimen, the mean (± SD) serum concentrations of adalimumab at week 52 were 15.3 ± 11.4 μg/mL (40/20 mg, weekly) and 6.7 ± 3.5 μg/mL
Danish: Hos patienter, hvis dosering øgedes fra hver anden uge til ugentlig, var den gennemsnitlige (± SD) serum-koncentration af adalimumab 15,3 ± 11,4 μg/ml (40/20 mg ugentlig) og 6,7 ± 3,5 μg/ml (20/10 mg ugentlig)
English: Cyltezo is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.
Danish: Cyltezo er indiceret til behandling af moderat til svær aktiv colitis ulcerosa hos voksne, som ikke har responderet tilfredsstillende på konventionel behandling inklusive glukokortikoider og 6-mercaptopurin (6-MP) eller azathioprin (AZA), eller som er intolerante over for eller har kontraindikationer mod sådanne behandlinger.
English: Children and adolescents from 4 to 17 years of age weighing 30 kg or more The recommended dose of Cyltezo is an initial dose of 40 mg, followed by 40 mg one week later.
Danish: Børn og unge fra 4 til 17 år, der vejer 30 kg eller mere Den anbefalede startdosis af Cyltezo er 40 mg, efterfulgt af 40 mg en uge senere.
English: • injection site reactions (including pain, swelling, redness or itching);
Danish: • reaktion ved injektionsstedet (herunder smerter, hævelse, rødme eller kløe)
English: In controlled trials of adalimumab (initial doses of 80 mg at week 0 followed by 40 mg every other week starting at week 1) in adult patients with uveitis up to 80 weeks with a median exposure of 166.5 days and 105.0 days in adalimumab-treated and control-treated patients, respectively, ALT elevations ≥ 3 x ULN occurred in 2.4 % of adalimumab-treated patients and 2.4 % of control-treated patients.
Danish: I kontrollerede studier af adalimumab hos voksne patienter med uveitis (startdosis på 80 mg i uge 0 efterfulgt af 40 mg hver anden uge med start i uge 1) i op til 80 uger med en gennemsnitligt behandlingstid på 166,5 dage for patienter behandlet med adalimumab og 105,0 dage for patienter i kontrol-armen, forekom ALAT-stigning ≥ 3 x ULN hos 2,4 % af patienterne i adalimumab-armen og hos 2,4 % af patienterne i kontrol-armen.
English: “Sharps” container (not included)
Danish: Beholder til ”kanyleaffald” (medfølger ikke)
English: Fatal and life-threatening infections (including sepsis, opportunistic infections and TB), HBV reactivation and various malignancies (including leukaemia, lymphoma and HSTCL) have also been reported with use of
Danish: Ved brug af adalimumab er der også rapporteret om letale og livstruende infektioner (inklusive sepsis, opportunistiske infektioner og tuberkulose), HBV-reaktivering og forskellige maligniteter (inklusive leukæmi, lymfomer og hepatosplenisk T-celle-lymfom).
English: MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING
Danish: FREMSTILLER(E) AF DET (DE) BIOLOGISK AKTIVE STOF(FER) OG FREMSTILLER(E) ANSVARLIG(E) FOR BATCHFRIGIVELSE BETINGELSER ELLER BEGRÆNSNINGER VEDRØRENDE UDLEVERING OG
English: Alternatively, if a patient has stopped Cyltezo and signs and symptoms of disease recur, Cyltezo may be readministered.
Danish: Alternativt, kan Cyltezo gen-administreres, hvis patienten er stoppet behandling med Cyltezo, og tegn og symptomer på sygdommen kommer igen.
English: Cyltezo is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and
Danish: Cyltezo er indiceret til behandling af svær kronisk plaque-psoriasis hos børn og unge fra 4 år, som har haft et utilstrækkeligt respons på, eller som ikke er egnede til topikal behandling eller lysbehandling.
English: Tell your doctor if you are taking azathioprine or
Danish: Fortæl din læge, hvis du får azathioprin eller mercaptopurin sammen med Cyltezo.
English: The needle cover of the syringe contains natural rubber (latex).
Danish: Beskyttelseshætten på injektionssprøjten indeholder naturgummi (latex).
English: RA study I at 24 weeks, RA study II at 26 weeks, and RA study III at 24 and 52 weeks 40 mg adalimumab administered every other week
Danish: RA-studie I efter 24 uger, RA-studie II efter 26 uger og RA-studie III efter 24 og 52 uger
English: Vision related effects were not numerically in favour of adalimumab for colour vision in Study UVI and for colour vision, peripheral vision
Danish: For synsrelaterede virkninger havde adalimumab ikke numerisk en fordel ved farvesyn i Studie UV I og ved farvesyn, langsyn og nærsyn i studie UV II.
English: Methotrexate should be continued
Danish: Der fortsættes med methotrexat under
English: One Cyltezo pre-filled syringe, removed from refrigerator.
Danish: En Cyltezo fyldt injektionssprøjte, tages ud af køleskabet.
English: Cyltezo is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults and adolescents from 12 years of age with an inadequate response to conventional systemic HS
Danish: Cyltezo er indiceret til behandling af aktiv moderat til svær hidrosadenitis suppurativa (svedkirtelbetændelse) hos voksne og unge fra 12 år, hvor responset på konventionel systemisk HS-behandling har været utilstrækkeligt (se pkt.
English: The double-blind period is followed by an open-label (OL) period during which patients received 24 mg/m² BSA of adalimumab up to a maximum of 40 mg every other week subcutaneously for up to an additional 192 weeks.
Danish: Den dobbeltblindede periode blev efterfulgt af en åben periode (OL), hvor patienterne fik adalimumab 24 mg/m2 legemsoverfladeareal (BSA) op til maksimalt 40 mg hver anden uge subkutant i op til yderligere 192 uger.
English: The recommended dose of Cyltezo for adult patients with rheumatoid arthritis is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection.
Danish: Den anbefalede dosis af Cyltezo til voksne patienter med reumatoid artrit er 40 mg adalimumab givet som enkeltdosis ved subkutan injektion hver anden uge.
English: In controlled trials of adalimumab (initial doses of 160 mg at week 0 and 80 mg at week 2, followed by 40 mg every week starting at week 4), in patients with hidradenitis suppurativa with a control period duration ranging from 12 to 16 weeks, ALT elevations ≥ 3 x ULN occurred in 0.3 % of adalimumab-treated patients
Danish: I kontrollerede studier med adalimumab (startdosis på 160 mg i uge 0 og 80 mg i uge 2, efterfulgt af 40 mg hver uge med start i uge 4) hos patienter med hidrosadenitis suppurativa med en kontrolperiode af 12 til 16 ugers varighed, forekom ALAT-stigning ≥ 3 x ULN hos 0,3% af patienterne i adalimumabbehandling og hos 0,6% af patienterne i kontrol-behandling.
English: Rare postmarketing cases of hepatosplenic T-cell lymphoma have been identified in patients treated with adalimumab.
Danish: Sjældne tilfælde af hepatosplenisk T-celle lymfom er blevet identificeret hos patienter, der blev behandlet med adalimumab, i perioden efter markedsføring.
English: Leukopenia (including neutropenia and agranulocytosis), anaemia
Danish: Blod og lymfesystem* Meget almindelig Leukopeni (inklusive neutropeni og agranulocytose), anæmi
English: • inflammation of the eyelid and eye swelling;
Danish: • betændelse i øjenlåget og hævede øjne
English: A 40 mg pre-filled syringe/pre-filled pen is available for patients to administer a full 40 mg dose.
Danish: En 40 mg fyldt injektionssprøjte/fyldt pen er tilgængelig til patienter, der skal administrere en fuld
English: Cyltezo is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and a corticosteroid and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies.
Danish: Cyltezo er indiceret til behandling af moderat til svær aktiv Crohns sygdom hos pædiatriske patienter (fra 6 år), som har haft utilstrækkeligt respons på konventionel behandling inklusive primær ernæringsbehandling og kortikosteroidbehandling og/eller immunmodulerende behandling, eller som er intolerante over for eller har kontraindikationer mod sådanne behandlinger.
English: Cyltezo is used to treat rheumatoid arthritis in adults.
Danish: Cyltezo bruges til at behandle reumatoid artrit hos voksne.
English: Patients received an initial dose of 80 mg adalimumab followed by 40 mg every other week (starting one week after the initial dose) or placebo for 26 weeks followed by open-label adalimumab treatment for an additional 26 weeks.
Danish: Patienterne fik en startdosis på 80 mg adalimumab efterfulgt af 40 mg hver anden uge med start en uge efter den første dosis eller placebo i 26 uger efterfulgt af åben adalimumab-behandling i yderligere 26 uger.
English: The recommended Cyltezo dose for patients with plaque psoriasis from 4 to 17 years of age is based on body weight (Table 3).
Danish: Den anbefalede Cyltezo-dosis til patienter med plaque psoriasis fra 4 til 17 år er baseret på legemsvægt (tabel 3).
English: Children, adolescents and adults with polyarticular juvenile idiopathic arthritis Children and adolescents from 2 years of age weighing 10 kg to less than 30 kg Cyltezo is only available as 40 mg pre-filled syringe and pre-filled pen.
Danish: Børn, unge og voksne med polyartikulær juvenil idiopatisk artrit Børn og unge fra 2 år, der vejer fra 10 kg til mindre end 30 kg Cyltezo fås kun som 40 mg fyldt injektionssprøjte/fyldt pen.
English: Multiple sclerosis, demyelinating disorders (e.g. optic neuritis, Guillain-Barré syndrome)
Danish: Multipel sklerose, demyeliniserende sygdomme (f.eks. opticus neuritis, Guillain-Barré syndrom) Synsforstyrrelser, konjunktivitis, blepharitis, hævede
English: At 8 years, 81 of 207 patients originally treated with 40 mg adalimumab every other week were evaluated radiographically.
Danish: 81 af 207 patienter, der oprindeligt blev behandlet med 40 mg adalimumab hver anden uge, blev radiografisk evalueret efter
English: Cyltezo is used to treat moderate to severe plaque psoriasis in adults.
Danish: Cyltezo bruges til at behandle moderat til alvorlig plaque-psoriasis hos voksne.
English: Table 14:
Danish: Tabel 14:
English: Cyltezo is used to treat ulcerative colitis in adults.
Danish: Cyltezo bruges til at behandle colitis ulcerosa hos voksne.
English: In controlled Phase 3 trials of adalimumab in patients with polyarticular juvenile idiopathic arthritis who were 4 to 17 years and enthesitis-related arthritis who were 6 to 17 years, ALT elevations ≥ 3 x ULN occurred in 6.1 % of adalimumab-treated patients and 1.3 % of control-treated patients.
Danish: I kontrollerede fase 3-studier af adalimumab hos patienter med polyartikulær juvenil idiopatisk artrit i alderen fra 4 til 17 år og hos patienter med entesopatirelateret artrit i alderen fra 6 til 17 år forekom ALAT-stigninger ≥ 3 x ULN hos 6,1 % af de adalimumab-behandlede patienter og hos 1,3 % af de kontrol-behandlede patienter.
English: • inflammations.
Danish: • migræne
English: Psoriatic arthritis and axial spondyloarthritis including ankylosing spondylitis There is no relevant use of adalimumab in the paediatric population for the indications of ankylosing
Danish: Psoriasisartrit og aksial spondyloartritis inklusive ankyloserende spondylitis Det er ikke relevant at anvende adalimumab til den pædiatriske population til indikationerne ankyloserende spondylitis og psoriatrisartrit.
English: The recommended dose of Cyltezo for patients with Crohn's disease from 6 to 17 years of age is based on body weight (Table 4).
Danish: Den anbefalede Cyltezo-dosis til patienter med Crohns sygdom fra 6 til 17 år er baseret på legemsvægt (tabel 4).
English: Cyltezo is indicated for the treatment of paediatric chronic non-infectious anterior uveitis in patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom
Danish: Cyltezo er indiceret til behandling af pædiatrisk kronisk non-infektiøs anterior uveitis hos børn fra 2 år, som har haft utilstrækkeligt respons på konventionel behandling eller, som er intolerante eller, som ikke er egnet til konventionel behandling.
English: Cyltezo is administered every other week via subcutaneous injection.
Danish: Cyltezo administreres hver anden uge som subkutan injektion.
English: Analysis Treatment
Danish: Behandlingsafbrydelse
English: Radiographic Mean Changes Over 12 Months in RA Study III
Danish: Gennemsnitlige radiografiske ændringer i uge 52 i RA-studie V
English: Mean steady-state trough levels of approximately 8 μg/mL were observed in ulcerative colitis patients who received a maintenance dose of 40 mg adalimumab every other week.
Danish: Gennemsnitlige dal-niveauer på omtrent 8 µg/ml ved steady state blev set hos patienter med colitis ulcerosa, som fik vedligeholdelsesdosis på 40 mg adalimumab hver anden
English: Table 19:
Danish: Tabel 19:
English: antagonist therapy to prevent HBV reactivation are not available.
Danish: Der foreligger ikke tilstrækkelige data fra anti-viral behandling i kombination med TNF-antagonister for at forebygge HBV-reaktivering hos patienter, som er bærere af HBV.
English: There is limited safety experience in patients undergoing arthroplasty while receiving adalimumab.
Danish: Der er begrænset erfaring med sikkerhed for patienter, som får artroplastik under behandling med
English: Adalimumab is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy (see section
Danish: Adalimumab er indiceret til behandling af aktiv entesopatirelateret artrit hos patienter fra 6 år, som har haft et utilstrækkeligt respons på, eller som er intolerante over for konventionel behandling
English: In paediatric uveitis, there is no experience in the treatment with adalimumab without concomitant treatment
Danish: Der er ingen erfaring ved behandling med adalimumab uden samtidig behandling med methotrexat i
English: The safety and efficacy of adalimumab were assessed in adult patients with non-infectious intermediate, posterior, and panuveitis, excluding patients with isolated anterior uveitis, in two randomised, double-masked, placebo-controlled studies (UV I and II).
Danish: Adalimumabs sikkerhed og virkning blev undersøgt i to randomiserede, dobbeltblindede, placebokontrollerede studier (UV I og UV II) hos voksne patienter med non-infektiøs intermediær, posterior og pan-uveitis; patienter med isoleret anterior uveitis blev ekskluderet.
English: Cyltezo may have a minor influence on the ability to drive and use machines.
Danish: 4.7 Virkning på evnen til at føre motorkøretøj og betjene maskiner Cyltezo kan i mindre grad påvirke evnen til at føre motorkøretøj og betjene maskiner.
English: Placebo/MTXAdalimumab/MTX (95 % Confidence Interval p-value
Danish: Adalimumab/MTX konfidensinterval p-værdi
English: Plaque psoriasis can also affect the nails, causing them to crumble, become thickened and lift away from the nail bed which can be painful.
Danish: Det får dem til at smuldre, blive fortykket og løftet fra neglelejet hvilket kan være meget smertefuldt.
English: Neurologic evaluation should be performed in patients with non-infectious intermediate uveitis prior to the initiation of Cyltezo therapy and regularly during treatment to assess for pre-existing or developing central demyelinating disorders.
Danish: Før initiering af Cyltezo og regelmæssigt under behandlingen bør der foretages en neurologisk udredning for at vurdere allerede eksisterende eller udvikling af demyeliniserende sygdomme hos patienter med non-infektiøs
English: Concomitant corticosteroids may be tapered in accordance with clinical practice starting two weeks after initiating treatment with Cyltezo.
Danish: I overensstemmelse med klinisk praksis kan samtidig steroidbehandling nedtrappes med start to uger
English: Table 13:
Danish: Tabel 13:
English: The safety and efficacy of adalimumab were assessed in over 1500 patients with moderately to severely active Crohn's disease (Crohn's Disease Activity Index (CDAI) ≥ 220 and ≤ 450) in randomised, double-blind, placebo-controlled studies.
Danish: Adalimumabs sikkerhed og virkning er undersøgt i randomiserede, dobbeltblindede, placebokontrollerede studier med over 1.500 patienter med moderat til svær aktiv Crohns sygdom (Crohns sygdoms-aktivitetsindeks (CDAI) ≥ 220 og ≤ 450).
English: 6 months 12 months
Danish: ASAS a 20 Uge 2 Uge 12
English: Contact your doctor if symptoms such as persistent unexplained rash, fever, joint pain or tiredness occur.
Danish: Fortæl din læge hvis du får symptomer såsom vedvarende uforklarligt udslæt, feber, ledsmerter eller
English: Cyltezo 40 mg solution for injection in pre-filled pen EU/1/17/1240/006
Danish: EU/1/17/1240/001 1 fyldt injektionssprøjte EU/1/17/1240/002 2 fyldte injektionssprøjter EU/1/17/1240/003 4 fyldte injektionssprøjter EU/1/17/1240/004 6 fyldte injektionssprøjter